This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

Pfizer

Status: Completed

Conditions: Arthritis Rheumatoid

Treatments: Drug: Etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT04267614

B1801411

Details and patient eligibility

About

This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.

Enrollment: 1,226 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed RA patients.
• 18 years old and above.
• Did not receive pervious biological treatment.

Exclusion criteria

• Had previous biological treatment
• Use etanercept for less than 1 year

Trial design

1,226 participants in 1 patient group

Patients with Rheumatoid Arthritis (RA)

Description:

Patients receiving etanercept from Baghdad teaching hospital registry(Rheumatology center) from 2012 till 2017. Patients were identified as receiving early versus delayed etanercept treatment.

Treatment:

Drug: Etanercept